SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-24-002032
Filing Date
2024-04-01
Accepted
2024-04-01 17:00:31
Documents
53
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR 12-31-23 cnspharma_i10k-123123.htm   iXBRL 10-K 930110
2 CONSENT OF MALONEBAILEY LLP cnspharma_ex2301.htm EX-23.1 2956
3 CERTIFICATION cnspharma_ex3101.htm EX-31.1 9855
4 CERTIFICATION cnspharma_ex3102.htm EX-31.2 9862
5 CERTIFICATION cnspharma_ex3201.htm EX-32.1 3504
6 CERTIFICATION cnspharma_ex3202.htm EX-32.2 3501
7 CNS PHARMACEUTICALS, INC. DODD-FRANK RESTATEMENT RECOUPMENT POLICY cnspharma_ex9700.htm EX-97.0 22442
  Complete submission text file 0001683168-24-002032.txt   4493467

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE cnsp-20231231.xsd EX-101.SCH 30617
9 XBRL CALCULATION FILE cnsp-20231231_cal.xml EX-101.CAL 31721
10 XBRL DEFINITION FILE cnsp-20231231_def.xml EX-101.DEF 163566
11 XBRL LABEL FILE cnsp-20231231_lab.xml EX-101.LAB 321820
12 XBRL PRESENTATION FILE cnsp-20231231_pre.xml EX-101.PRE 269597
56 EXTRACTED XBRL INSTANCE DOCUMENT cnspharma_i10k-123123_htm.xml XML 484851
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39126 | Film No.: 24810601
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)